A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy. uri icon

authors

  • Adam Spivak, MD, FACP
  • Lai, Jun
  • Kennedy, Margene
  • Chander, Geetanjali
  • Siliciano, Robert F
  • Siliciano, Janet D
  • Deeks, Steven G
  • Andrade, Adriana
  • Eisele, Evelyn
  • Hoh, Rebecca
  • Bacchetti, Peter
  • Bumpus, Namandjé N
  • Emad, Fatemeh
  • Buckheit, Robert
  • McCance-Katz, Elinore F

publication date

  • January 1, 2013